[1]
P. Di Benedetto, “Rivaroxaban and early periprostethic joint infection: our experience”, Acta Biomed, vol. 88, no. 4 -S, pp. 38–42, Oct. 2017, doi: 10.23750/abm.v88i4 -S.6792.